Redwood City Jobs

Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases. The Company's proprietary ARC-sparX platform separates the tumor-recognition and tumor-killing functions of conventional CAR-T cell therapies: (1) sparX (soluble protein antigen-receptor X-linkers) proteins recognize and bind specific antigens on diseased cells and flag those cells for destruction; and (2) ARC-T (Antigen Receptor Complex-T) cells bind the sparX proteins and kill the flagged cells. Arcellx has developed a collection of sparX proteins that bind different cell surface antigens. Administration of alternate sparX proteins can redirect ARC-T cells to different disease antigens to potentially address relapsed and refractory disease due to tumor heterogeneity or antigen escape. Additionally, ARC-T cell activity can be curbed as needed by controlling the dose and frequency of sparX administration.

TigerGraph operates as a software development company. The Company offers real-time graph analytics platform for enterprise. TigerGraph provides personalized recommendations, fraud prevention, supply-chain logistics, company knowledge graph, and other features. TigerGraph serves customers in the State of California.

Revolution Medicines, Inc. operates as an oncology company. The Company discovers novel targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways. Revolution Medicines serves customers worldwide.

Zilliz is a leading vector database company for production-ready AI. Built by the engineers who created Milvus, the world's most popular open-source vector database, Zilliz is on a mission to unleash data insights with AI. The company builds next-generation database technologies to help organizations rapidly create AI/ML applications, and unlock the potential of unstructured data. By taking the burden of complex data infrastructure management off of its users, Zilliz is committed to bringing the power of AI to every corporation, every organization, and every individual. Headquartered in San Francisco, Zilliz is backed by a number of prestigious investors, including Hillhouse Capital, Aramco's Prosperity7 Ventures, Temasek's Pavilion Capital, 5Y Capital, Yunqi Partners, Trustbridge Partners and others. Zilliz's technologies and products help over 1000 organizations worldwide easily create AI applications in various scenarios, including computer vision, image retrieval, video analysis, NLP, recommendation engines, targeted ads, customized search, smart chatbots, fraud detection, network security, new drug discovery, and much more. Learn more at zilliz.com or follow @zilliz_universe.

Altos Labs, Inc. is an American biotechnology research company. Altos Labs' goal is to develop life extension therapies that can halt or reverse the human aging process. Specialized cell therapies based on induced pluripotent stem cells are to be developed for this purpose. The company was started in 2022.